loading page

Extracellular expression and characterization of an α-glucosidase from Oryza sativa and its transglycosylation for synthesis of 2-O-α-D-glucopyranosyl-L-ascorbic acid
  • +4
  • Xuelian Qi,
  • Junlan Shao,
  • Yinchu Cheng,
  • Xiaoying He,
  • Yan Li,
  • Honghua Jia,
  • Ming Yan
Xuelian Qi
Nanjing Tech University

Corresponding Author:[email protected]

Author Profile
Junlan Shao
Nanjing Tech University
Author Profile
Yinchu Cheng
Nanjing Tech University
Author Profile
Xiaoying He
Nanjing Tech University
Author Profile
Yan Li
Nanjing Tech University
Author Profile
Honghua Jia
Nanjing Tech University
Author Profile
Ming Yan
Nanjing Tech University
Author Profile


Abstract: 2-O-α-D-Glucopyranosyl-L-ascorbic acid (AA-2G) is an important industrial derivative of L-ascorbic acid (AA), which has the distinct advantages of non-reducibility, antioxidation, and reproducible decomposition into L-ascorbic acid and glucose. Enzymatic synthesis is a preferred method for AA-2G production over alternative chemical synthesis owing to the regioselective glycosylation reaction. α-Glucosidase, an enzyme classed into O- glycoside hydrolases, may be used in glycosylation reactions to synthesize AA-2G. Here, one α-glucosidase from Oryza sativa (rAGL) was recombinantly produced in Pichia pastoris GS115 and used for biosynthesis of AA-2G with few intermediates and byproducts. The extracellular rAGL reached 9.11 U/mL after fed-batch cultivation for 102 h in a 5-L fermenter. The specific activity of purified rAGL is 49.83 U/mg at 37 °C and pH 4.0. The optimal temperature of rAGL was 65 °C, and it was stable below 55 °C. rAGL was active over the range of pH 3.0–7.0, with the maximal activity at pH 4.0. Under the condition of 37 °C , pH 4.0, equimolar maltose and AA·Na, 8.7±0.4 g/L of AA-2G was synthesized by rAGL. These studies lay the basis for the industrial application of recombinant α-glucosidase. Keywords: α-Glucosidase; Oryza sativa; 2-O-α-D-glucopyranosyl-L-ascorbic acid; Transglycosylation; Pichia pastoris
16 Apr 2021Submitted to Biotechnology Journal
16 Apr 2021Submission Checks Completed
16 Apr 2021Assigned to Editor
14 May 2021Reviewer(s) Assigned
27 May 2021Editorial Decision: Revise Minor
10 Jun 20211st Revision Received
10 Jun 2021Assigned to Editor
10 Jun 2021Submission Checks Completed
10 Jun 2021Reviewer(s) Assigned
22 Jun 2021Editorial Decision: Revise Minor
29 Jun 20212nd Revision Received
01 Jul 2021Submission Checks Completed
01 Jul 2021Assigned to Editor
01 Jul 2021Reviewer(s) Assigned
09 Jul 2021Editorial Decision: Revise Minor
31 Jul 20213rd Revision Received
02 Aug 2021Assigned to Editor
02 Aug 2021Submission Checks Completed
12 Aug 2021Editorial Decision: Accept